title: COX-2 inhibitors and risk of heart failure.
authors.forename: Martin C
authors.initials: MC
authors.lastname: Kammerl
authors.forename: Jens
authors.initials: J
authors.lastname: Debler
authors.forename: Günter A
authors.initials: GA
authors.lastname: Riegger
authors.forename: Bernhard K
authors.initials: BK
authors.lastname: Krämer
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D000068579:Celecoxib; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects*; D006333:Heart Failure / Q000139:chemically induced*; D006801:Humans; D007783:Lactones / Q000009:adverse effects; D011720:Pyrazoles; D013449:Sulfonamides / Q000009:adverse effects; D013450:Sulfones
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors; D007783:Lactones; D011720:Pyrazoles; D013449:Sulfonamides; D013450:Sulfones; C116926:rofecoxib; D000068579:Celecoxib